Alkermes plc (($ALKS)) announced an update on their ongoing clinical study. Alkermes plc is conducting a Phase 3 clinical study titled ...

Abilify (aripiprazole) is a prescription atypical antipsychotic that treats depression, schizophrenia, bipolar disorder, irritability related to autism, and specific Tourette's symptoms. While most ...

Dear Doctor: My mother is suffering from dementia and is increasingly difficult, but I'd hate for her to be given antipsychotics. Isn't there anything else that could be done to keep her calm? Dear ...

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

The US Food and Drug Administration (FDA) is due to issue a decision by September 26 on the approval of KarXT, a potential first-in-class antipsychotic. If approved, it would be the first drug with a ...

Donald Goff, Jeffrey Lieberman, and colleagues recently published a review article entitled “The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia” in the American ...

“The worse the data on the elderly got, and the worse the potential for the FDA reaction to it got, the more J&J seemed to intensify its sales effort.” So writes investigative journalist Steven Brill ...